The trabecular bone score is a measure of bone texture correlated with bone microarchitecture and a marker for the risk of osteoporosis. Introduced in 2008, its main projected use is alongside measures of bone density in better predicting fracture risk in people with metabolic bone problems.
Video Trabecular bone score
Need for a marker of microarchitecture
To diagnose osteoporosis, despite the inclusion of bone mineral density (BMD), biological markers and clinical factors of fracture risk, many not detected patients are at risk and many fractures are not explained. bone mineral density is an assessment of the quantity of bone. It does not provide information on bone quality, another important parameter to describe the bone. In addition, clinical risk factors for fracture are at best an indirect assessment of the bone quality. One way to describe the quality of the bone is to assess its microarchitecture. Bone microarchitecture is related to the mechanical strength of bone and hence its greater or lesser risk of fracture. Indeed, for the same quantity of bone, different mechanically resistant bone structures may exist (few large trabeculae or numerous thin trabeculae that are mechanically stronger). Actually, bone loss is often accompanied by a deterioration of bone architecture, resulted in a decreased number of trabeculae, increased inter-trabecular distances, and a loss connectivity of the trabecular meshwork. Moreover, reduction of cortical bone thickness and increased porosity accompany trabecular bone loss, and in particular promote the fragility of the femoral neck. Osteoporotic bone is called "porous".
Maps Trabecular bone score
Technical
The trabecular bone score is a textural parameter that can be applied to DEXA, which quantifies the local variations in gray level. TBS is derived from the evaluation of the experimental variogram, obtained from the grayscale DEXA.
It was found that TBS is a reflection of the structural condition of the bone microarchitecture. TBS is strongly correlated with the number of trabeculae and their connectivity and negatively with the space between trabeculae. That is to say that a high TBS value means that microarchitecture bone is dense, well connected with little spaces between trabeculaes. Conversely, a low TBS value means that the microarchitecture of bone is incomplete and poorly connected with wide spaces between trabeculae.
Clinical use
From a clinical standpoint, TBS provides:
- assessment the risk of fracture;
- in combination with BMD, increase the number of patients at risk (correctly) identified;
- improvement the management of patients with secondary osteoporosis;
- follow-up of the evolution of microarchitecture of a patient over time;
- monitoring of the effect of anti-resorptive or anabolic.
All these studies have shown that TBS can be used as a clinical risk factor for osteoporotic fracture since it is reversible (with or without treatment), quantitative and independent of BMD. It should therefore be used as such in the same way that taking corticosteroids, rheumatoid arthritis or prevalent fracture after age 50.
Notes and references
Source of article : Wikipedia
0 Comments